The FDA just issued new guidance that reclassifies prescription‑drug software as a Class II device—devs must now prove compliance or risk enforcement.
© 2026 GNewsX. All rights reserved.
The FDA just issued new guidance that reclassifies prescription‑drug software as a Class II device—devs must now prove compliance or risk enforcement.
© 2026 GNewsX. All rights reserved.
GNewsX uses cookies to improve your browsing experience, analyze website traffic, and support essential website functions. By continuing to use this website, you agree to our use of cookies as described in our Cookie Policy. Accept Cookies Read More